• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中性粒细胞与淋巴细胞比值在慢性肾脏病患者中的预后作用。

Prognostic role of the neutrophil-to-lymphocyte ratio in patients with chronic kidney disease.

机构信息

Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.

出版信息

Korean J Intern Med. 2023 Sep;38(5):725-733. doi: 10.3904/kjim.2023.171. Epub 2023 Aug 17.

DOI:10.3904/kjim.2023.171
PMID:37586809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10493449/
Abstract

BACKGROUND/AIMS: The neutrophil-to-lymphocyte ratio (NLR) has a prognostic value in cardiovascular disease, infection, inflammatory disease, and several malignancies. Therefore, the NLR has a possible predictive value in patients with chronic kidney disease (CKD), but this predictive value has not been validated. Here, we aimed to investigate the possibility of NLR as a predictor of CKD progression.

METHODS

This retrospective observational study included 141 patients with non-dialysis CKD. The participants were divided into terciles (T1, T2, and T3) according to NLR. The primary outcome was defined as a composite kidney event, which included a decline in the estimated glomerular filtration rate (eGFR) of at least 50% or initiation of renal replacement therapy during the follow-up period.

RESULTS

The mean follow-up duration was 5.45 ± 2.11 years. The mean NLRs were 1.35 ± 0.05 in T1 (n = 47), 2.16 ± 0.04 in T2 (n = 47), and 4.29 ± 0.73 in T3 (n = 47). The group with the highest NLR (T3) had higher baseline CKD and serum creatinine and lower eGFR levels than the group with the lowest NLR (T1). The cumulative incidence rate of composite kidney events was significantly higher in T3 compared with T1 (p < 0.001, log-rank test). Cox regression analysis revealed that high NLR was associated with the risk of composite kidney events (adjusted hazard ratio, 3.33; 95% confidence interval, 1.43-7.76).

CONCLUSION

A higher NLR reflects the more advanced stage of CKD and suggests a role for NLR as a biomarker for predicting CKD progression.

摘要

背景/目的:中性粒细胞与淋巴细胞比值(NLR)在心血管疾病、感染、炎症性疾病和多种恶性肿瘤中具有预后价值。因此,NLR 可能对慢性肾脏病(CKD)患者具有预测价值,但这一预测价值尚未得到验证。在这里,我们旨在研究 NLR 作为 CKD 进展预测因子的可能性。

方法

这是一项回顾性观察性研究,纳入了 141 名非透析 CKD 患者。参与者根据 NLR 分为三分位(T1、T2 和 T3)。主要结局定义为复合肾脏事件,包括在随访期间 eGFR 至少下降 50%或开始肾脏替代治疗。

结果

平均随访时间为 5.45±2.11 年。T1 组(n=47)、T2 组(n=47)和 T3 组(n=47)的平均 NLR 分别为 1.35±0.05、2.16±0.04 和 4.29±0.73。NLR 最高的 T3 组(n=47)的基线 CKD、血清肌酐较高,eGFR 水平较低。与 NLR 最低的 T1 组(n=47)相比,T3 组的复合肾脏事件累积发生率显著更高(p<0.001,对数秩检验)。Cox 回归分析显示,高 NLR 与复合肾脏事件的风险相关(调整后的危险比,3.33;95%置信区间,1.43-7.76)。

结论

较高的 NLR 反映了 CKD 更晚期的阶段,并提示 NLR 可作为预测 CKD 进展的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d7/10493449/4f75a1622b77/kjim-2023-171f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d7/10493449/0ca31031864c/kjim-2023-171f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d7/10493449/93126a72e49f/kjim-2023-171f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d7/10493449/e2ead84e57ad/kjim-2023-171f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d7/10493449/4f75a1622b77/kjim-2023-171f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d7/10493449/0ca31031864c/kjim-2023-171f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d7/10493449/93126a72e49f/kjim-2023-171f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d7/10493449/e2ead84e57ad/kjim-2023-171f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d7/10493449/4f75a1622b77/kjim-2023-171f4.jpg

相似文献

1
Prognostic role of the neutrophil-to-lymphocyte ratio in patients with chronic kidney disease.中性粒细胞与淋巴细胞比值在慢性肾脏病患者中的预后作用。
Korean J Intern Med. 2023 Sep;38(5):725-733. doi: 10.3904/kjim.2023.171. Epub 2023 Aug 17.
2
Does neutrophyl to lymphocyte ratio really predict chronic kidney disease progression?中性粒细胞与淋巴细胞比值真的能预测慢性肾脏病的进展吗?
Int Urol Nephrol. 2019 Jan;51(1):129-137. doi: 10.1007/s11255-018-1994-7. Epub 2018 Oct 1.
3
High neutrophil/lymphocyte ratio is associated with poor renal outcomes in Japanese patients with chronic kidney disease.高中性粒细胞/淋巴细胞比值与日本慢性肾脏病患者的不良肾脏结局相关。
Ren Fail. 2019 Nov;41(1):238-243. doi: 10.1080/0886022X.2019.1595645.
4
Neutrophil-to-lymphocyte ratio and incident end-stage renal disease in Chinese patients with chronic kidney disease: results from the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE).中性粒细胞与淋巴细胞比值与中国慢性肾脏病患者终末期肾病的发生:来自中国慢性肾脏病队列研究(C-STRIDE)的结果。
J Transl Med. 2019 Mar 15;17(1):86. doi: 10.1186/s12967-019-1808-4.
5
Higher Neutrophil-To-Lymphocyte Ratio Was Associated with Increased Risk of Chronic Kidney Disease in Overweight/Obese but Not Normal-Weight Individuals.高中性粒细胞与淋巴细胞比值与超重/肥胖人群慢性肾脏病风险增加相关,但与体重正常人群无关。
Int J Environ Res Public Health. 2022 Jun 30;19(13):8077. doi: 10.3390/ijerph19138077.
6
Association of neutrophil-to-lymphocyte ratio and risk of cardiovascular or all-cause mortality in chronic kidney disease: a meta-analysis.中性粒细胞与淋巴细胞比值与慢性肾脏病患者心血管疾病或全因死亡风险的关联:一项荟萃分析
Clin Exp Nephrol. 2021 Feb;25(2):157-165. doi: 10.1007/s10157-020-01975-9. Epub 2020 Oct 6.
7
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用:对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
8
Low renal replacement therapy incidence among slowly progressing elderly chronic kidney disease patients referred to nephrology care: an observational study.转诊至肾脏病科的进展缓慢的老年慢性肾脏病患者肾替代治疗发生率较低:一项观察性研究。
BMC Nephrol. 2017 Feb 10;18(1):59. doi: 10.1186/s12882-017-0473-1.
9
Non-High-Density Lipoprotein Cholesterol and Progression of Chronic Kidney Disease: Results from the KNOW-CKD Study.非高密度脂蛋白胆固醇与慢性肾脏病的进展:来自 KNOW-CKD 研究的结果。
Nutrients. 2022 Nov 7;14(21):4704. doi: 10.3390/nu14214704.
10
Does neutrophil to lymphocyte ratio demonstrate deterioration in renal function?中性粒细胞与淋巴细胞比值是否显示肾功能恶化?
Ren Fail. 2018 Nov;40(1):209-212. doi: 10.1080/0886022X.2018.1455590.

引用本文的文献

1
Serum Peroxiredoxins Reflect Oxidative Stress and Predict Renal Outcomes in Patients with Glomerulonephritis.血清过氧化物酶体增殖物激活受体反映氧化应激并预测肾小球肾炎患者的肾脏预后。
Int J Mol Sci. 2025 Aug 9;26(16):7708. doi: 10.3390/ijms26167708.
2
The association between neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, red blood cell distribution width, and physical function in elderly non-dialysis patients with chronic kidney disease.老年非透析慢性肾脏病患者中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值、红细胞分布宽度与身体功能之间的关联
BMC Geriatr. 2025 Aug 2;25(1):580. doi: 10.1186/s12877-025-06277-x.
3

本文引用的文献

1
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.KDIGO 2022慢性肾脏病糖尿病管理临床实践指南
Kidney Int. 2022 Nov;102(5S):S1-S127. doi: 10.1016/j.kint.2022.06.008.
2
Prognostic role of baseline neutrophil-to-lymphocyte ratio in metastatic solid tumors.基线中性粒细胞与淋巴细胞比值在转移性实体瘤中的预后作用。
Mol Clin Oncol. 2020 Oct;13(4):25. doi: 10.3892/mco.2020.2095. Epub 2020 Jul 16.
3
High neutrophil/lymphocyte ratio is associated with poor renal outcomes in Japanese patients with chronic kidney disease.
Prognostic value of neutrophil-to-lymphocyte ratio for the clinical outcomes of chronic kidney diseases: an update systematic review and meta-analysis.
中性粒细胞与淋巴细胞比值对慢性肾脏病临床结局的预后价值:一项更新的系统评价和荟萃分析
BMC Nephrol. 2025 Jul 28;26(1):419. doi: 10.1186/s12882-025-04363-1.
4
Clinical benefits and future directions of medium cut-off membranes in hemodialysis: a comprehensive review.血液透析中中等截留量膜的临床益处及未来方向:一项综述
Korean J Intern Med. 2025 Jul;40(4):557-570. doi: 10.3904/kjim.2025.049. Epub 2025 Jul 1.
5
New and Emerging Biomarkers in Chronic Kidney Disease.慢性肾脏病中的新型和新兴生物标志物
Biomedicines. 2025 Jun 10;13(6):1423. doi: 10.3390/biomedicines13061423.
6
Effects of a continuous remote care intervention including nutritional ketosis on kidney function and inflammation in adults with type 2 diabetes: a latent class trajectory analysis.包括营养性生酮饮食在内的持续远程护理干预对2型糖尿病成人肾功能和炎症的影响:一项潜在类别轨迹分析
Front Nutr. 2025 Jun 6;12:1609737. doi: 10.3389/fnut.2025.1609737. eCollection 2025.
7
Assessing the Impact of Inflammation on Erythropoietin Resistance in Hemodialysis: The Role of the NLR.评估炎症对血液透析中促红细胞生成素抵抗的影响:中性粒细胞与淋巴细胞比值的作用
J Clin Med. 2025 May 13;14(10):3411. doi: 10.3390/jcm14103411.
8
Nutritional Status, Uremic Toxins, and Metabo-Inflammatory Biomarkers as Predictors of Two-Year Cardiovascular Mortality in Dialysis Patients: A Prospective Study.营养状况、尿毒症毒素和代谢炎症生物标志物作为透析患者两年心血管死亡率的预测指标:一项前瞻性研究
Nutrients. 2025 Mar 16;17(6):1043. doi: 10.3390/nu17061043.
9
Are the Hematological Parameters Useful in Differentiating Acute Pyelonephritis from Cystitis in Patients with Chronic Kidney Disease?血液学参数对鉴别慢性肾脏病患者的急性肾盂肾炎和膀胱炎有用吗?
Maedica (Bucur). 2024 Sep;19(3):511-518. doi: 10.26574/maedica.2024.19.3.511.
10
TH1 Cell Frequency and Neutrophil-to-Lymphocyte Ratio in Hemodialysis: Potential Contributions to Patient Monitoring.血液透析中TH1细胞频率与中性粒细胞与淋巴细胞比值:对患者监测的潜在贡献
Biomedicines. 2024 Sep 26;12(10):2188. doi: 10.3390/biomedicines12102188.
高中性粒细胞/淋巴细胞比值与日本慢性肾脏病患者的不良肾脏结局相关。
Ren Fail. 2019 Nov;41(1):238-243. doi: 10.1080/0886022X.2019.1595645.
4
Does neutrophyl to lymphocyte ratio really predict chronic kidney disease progression?中性粒细胞与淋巴细胞比值真的能预测慢性肾脏病的进展吗?
Int Urol Nephrol. 2019 Jan;51(1):129-137. doi: 10.1007/s11255-018-1994-7. Epub 2018 Oct 1.
5
Prognostic value of neutrophil to lymphocyte ratio in heart failure patients.中性粒细胞与淋巴细胞比值对心力衰竭患者的预后价值。
Clin Chim Acta. 2018 Oct;485:44-49. doi: 10.1016/j.cca.2018.06.021. Epub 2018 Jun 19.
6
The association of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with clinical outcomes in geriatric patients with stage 3-5 chronic kidney disease.老年3-5期慢性肾脏病患者中性粒细胞/淋巴细胞比值和血小板/淋巴细胞比值与临床结局的相关性
Acta Clin Belg. 2016 Aug;71(4):221-6. doi: 10.1080/17843286.2016.1159797. Epub 2016 May 20.
7
Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease.中性粒细胞与淋巴细胞比值在慢性肾脏病患者炎症评估中的应用。
Ren Fail. 2013;35(1):29-36. doi: 10.3109/0886022X.2012.734429. Epub 2012 Nov 1.
8
Role of neutrophil/lymphocyte ratio in prediction of disease progression in patients with stage-4 chronic kidney disease.中性粒细胞/淋巴细胞比值在预测 4 期慢性肾脏病患者疾病进展中的作用。
J Nephrol. 2013 Mar-Apr;26(2):358-65. doi: 10.5301/jn.5000152. Epub 2012 May 8.
9
Elevated neutrophil to lymphocyte ratio predicts overall and cardiovascular mortality in maintenance peritoneal dialysis patients.中性粒细胞与淋巴细胞比值升高可预测维持性腹膜透析患者的全因和心血管死亡率。
Int Urol Nephrol. 2012 Oct;44(5):1521-8. doi: 10.1007/s11255-012-0130-3.
10
The relationship between neutrophil-to-lymphocyte ratio and inflammation in end-stage renal disease patients.中性粒细胞与淋巴细胞比值与终末期肾病患者炎症的关系。
Ren Fail. 2012;34(2):155-9. doi: 10.3109/0886022X.2011.641514. Epub 2011 Dec 16.